Skip to content
PubMed This is a summary of 55 peer-reviewed journal articles Updated
Orthopedics

Navigating Ollier Disease: A Comprehensive Guide for Families

At a Glance

Ollier disease is a rare, non-inherited skeletal disorder that causes benign cartilage tumors (enchondromas) to grow inside bones. Managing the condition involves orthopedic treatments to correct bone growth and lifelong monitoring to watch for malignant transformation.

Ollier disease is a rare, non-hereditary skeletal disorder characterized by the presence of multiple enchondromas—benign tumors made of cartilage that grow within the bones [1][2]. A diagnosis can be overwhelming, but this guide is designed to empower you with evidence-based information to help you manage the condition and advocate for the best possible care.

The information in this resource is divided into focused sections to help you navigate different aspects of the disease, from initial diagnosis to long-term management.

Common questions in this guide

What is Ollier disease?
Ollier disease is a rare, non-hereditary skeletal disorder. It is characterized by the growth of multiple benign cartilage tumors, called enchondromas, inside the bones.
What are the warning signs and symptoms of Ollier disease?
Common symptoms include limb length differences, bone bowing, and pathological fractures. Pain at rest is a critical red flag that requires immediate medical attention from your care team.
Is Ollier disease genetic or inherited?
No, Ollier disease is not inherited from your parents. It is caused by genetic mutations, typically in the IDH1 or IDH2 genes, that occur randomly after conception in a process called somatic mosaicism.
How are the bone growth issues in Ollier disease treated?
Treatment typically focuses on managing bone growth challenges and maintaining mobility. Orthopedic specialists may use traditional external fixators or modern internal lengthening nails to correct limb length differences and repair fractures.
Why do patients with Ollier disease need lifelong monitoring?
Because the benign cartilage tumors in Ollier disease carry a lifelong risk of turning into a malignancy, proactive long-term monitoring is essential. Regular clinical exams and imaging studies help your care team detect any changes early.
What specialists should be on our Ollier disease care team?
Given the complexity of the condition, your core team should ideally include orthopedic surgeons, medical geneticists, and specialists experienced in rare bone diseases. Many families also benefit from a patient navigator or psychosocial support specialist.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my/my child's specific case, what specialists should we include in our core care team?
  2. 2.How frequently should we be scheduling clinical exams compared to imaging?
  3. 3.Is there a patient navigator or psychosocial support specialist affiliated with this clinic who has experience with rare bone diseases?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (5)
  1. 1

    Teaching NeuroImage: Histopathologically Confirmed Intracranial Enchondroma/Low-Grade Chondrosarcoma and IDH1-Mutated Diffuse Glioma in Ollier Disease.

    Gregory TA, Taylor LP

    Neurology 2021; (97(17)):e1747-e1748 doi:10.1212/WNL.0000000000012269.

    PMID: 34039720
  2. 2

    Ollier Disease: A Case Series and Literature Review.

    Markevičiūtė V, Markevičiūtė MŠ, Stravinskas M

    Acta medica Lituanic 2021; (28(1)):181-188 doi:10.15388/Amed.2021.28.1.8.

    PMID: 34393643
  3. 3

    Update on the imaging features of the enchondromatosis syndromes.

    Sharif B, Lindsay D, Saifuddin A

    Skeletal radiology 2022; (51(4)):747-762 doi:10.1007/s00256-021-03870-0.

    PMID: 34302201
  4. 4

    Gene of the month: IDH1.

    Bruce-Brand C, Govender D

    Journal of clinical pathology 2020; (73(10)):611-615 doi:10.1136/jclinpath-2020-206813.

    PMID: 32727816
  5. 5

    Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes.

    Michaeli O, Kim SY, Mitchell SG, et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research 2025; (31(3)):457-465 doi:10.1158/1078-0432.CCR-24-2171.

    PMID: 39601780

This guide is for informational purposes only and does not replace professional medical advice. Always consult your orthopedic specialist and care team about your specific diagnosis and treatment plan.

Get notified when new evidence is published on Ollier disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.